Sign Up Today and Learn More About Tropic Biosciences Stock
Invest in or calculate the value of your shares in Tropic Biosciences or other pre-IPO companies through EquityZen's platform.
Tropic Biosciences Stock
Tropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits.
About Tropic Biosciences Stock
Founded
2016
Industries
Software, Artificial Intelligence, Data and Analytics
Tropic Biosciences Press Mentions
Stay in the know about the latest news on Tropic Biosciences
Tropic: $105 Million Raised To Scale Gene-Edited Tropical Crops And Banana Production
pulse2 • Mar 15, 2026
Tropic raises $105M to scale gene-edited bananas
thenextweb • Mar 14, 2026
Gene-edited bananas, gas-sniffing satellites, virtual engineers: a week in impact funding
impactloop • Mar 14, 2026
Tropic’s €91.3M scales gene-edited bananas that beat Panama disease worldwide
techfundingnews • Mar 14, 2026
UK AgTech startup Tropic secures €91.3 million to bring gene-edited bananas and climate-resilient crops to market
eu-startups • Mar 13, 2026
Tropic Biosciences Management
Leadership team at Tropic Biosciences
Board of Director
Tom Greene
Chief Commercial Officer
Jack Peart
Join now and verify your accreditation status to gain access to:
- Tropic Biosciences Current Valuation
- Tropic Biosciences Stock Price
- Tropic Biosciences Management
- Available deals in Tropic Biosciences and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Tropic Biosciences Cap Table and Funding History by Share Class and Liquidity Preferences
- Tropic Biosciences Revenue and Financials
- Tropic Biosciences Highlights
- Tropic Biosciences Business Model
- Tropic Biosciences Risk Factors
- Tropic Biosciences Research Report from SACRA Research
Trading Tropic Biosciences Stock
How to invest in Tropic Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like Tropic Biosciences through EquityZen funds. These investments are made available by existing Tropic Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Tropic Biosciences stock?
Shareholders can sell their Tropic Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."